Drug Approval | March 14, 2022
USFDA approves Zydus’ Colestipol Hydrochloride tablets
It is only the second generic application approved by the USFDA
It is only the second generic application approved by the USFDA
Ritika has also extensively worked with clients such as WHO, GAVI Alliance, USAID, Gilead, Novartis, Sanofi Pasteur
RNA, cell & gene therapies, artificial intelligence, CRISPR and oncology-related deals dominate the landscape
In numerous neurological and rare disorders, where clinical characteristics can be confusing, NGS-based approaches have demonstrated considerable increases in disease detection rates over other approaches
The open-label, multicenter, randomized Phase 1 trial is designed to evaluate the safety and immunogenicity of experimental HIV trimer mRNA vaccines
The award recognizes and supports promising women scientists
Most recently, Rollins was the Chief Information Officer at UnitedHealthcare
First and only once-weekly patch for convenient, well-tolerated delivery of most used drug for the treatment of Alzheimer's-related dementia
Agreement builds on 15 years of successful collaboration between AbbVie and Richter, including globally launched cariprazine products
The primary objective of this Phase 1 study is to investigate the safety and tolerability of GZR18 in healthy volunteers
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
